Which symptom is commonly associated with Multiple Myeloma?

Which symptom is commonly associated with Multiple Myeloma?

• A. Hypoglycemia
• B. Increased susceptibility to infection
• C. Jaundice
• D. Vision problems

Answer: (B)

Increased susceptibility to infection is a hallmark symptom associated with Multiple Myeloma. This condition is characterized by an overproduction of abnormal plasma cells, which not only produce ineffective immunoglobulins but also suppress the normal immune function. This impairment in the immune system leads to a higher risk of infections, particularly because patients may have reduced levels of functional antibodies, making it difficult for the body to respond effectively to foreign pathogens. Other symptoms may be present in Multiple Myeloma, but increased susceptibility to infection is a key consequence of the disease's impact on the immune system, reflecting the underlying pathology. In contrast, symptoms such as hypoglycemia, jaundice, and vision problems are not typically associated with Multiple Myeloma, thus highlighting the importance of recognizing the immune dysfunction central to this malignancy.

Increased susceptibility to infection is a hallmark symptom associated with Multiple Myeloma. This condition is characterized by an overproduction of abnormal plasma cells, which not only produce ineffective immunoglobulins but also suppress the normal immune function. This impairment in the immune system leads to a higher risk of infections, particularly because patients may have reduced levels of functional antibodies, making it difficult for the body to respond effectively to foreign pathogens.

Other symptoms may be present in Multiple Myeloma, but increased susceptibility to infection is a key consequence of the disease's impact on the immune system, reflecting the underlying pathology. In contrast, symptoms such as hypoglycemia, jaundice, and vision problems are not typically associated with Multiple Myeloma, thus highlighting the importance of recognizing the immune dysfunction central to this malignancy.